Raily Aesthetic Medicine International Holdings Limited, an investment holding company, provides aesthetic medical services in the People's Republic of China. It operates through Aesthetic Medical Services, Consulting Services, and Aesthetic Medical Equipment Products segments. The company provides aesthetic surgery services, including aesthetic surgery services comprising aesthetic surgical procedures performed on various parts of the face or body; minimally invasive aesthetic services, such as aesthetic injection procedures; aesthetic dermatology services that consists of various aesthetic energy-based procedures and photoelectric items; aesthetic dental services that include orthodontics, dental implant, and dental whitening; and aesthetic medical management consulting services. It also offers aesthetic medical equipment products comprising collagen injection products, surgical implants, and aesthetic medical skincare products. In addition, the company owns and operates a network of private for-profit aesthetic medical institutions; and trades in medical equipment. It serves individual retail clients and aesthetic medical institutions. Raily Aesthetic Medicine International Holdings Limited was founded in 2008 and is headquartered in Hangzhou, the People's Republic of China. The company operates as a subsidiary of Ruide Consultation Limited.
Research context
Raily Aesthetic Medicine International Holdings Limited appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 7 months ago
From a valuation standpoint, the stock is 90.8% cheaper than other stocks from the sector with a price to sales ratio of 3.7.
Based on the above factors, Raily Aesthetic Medicine International Holdings Limited gets an overall score of 1/5.